Cargando…
Therapeutic efficiency of the APAF‐1 antagonist LPT99 in a rat model of cisplatin‐induced hearing loss
Autores principales: | Murillo‐Cuesta, Silvia, Celaya, Adelaida M, Cervantes, Blanca, Bermúdez‐Muñoz, Jose M, Rodríguez‐de la Rosa, Lourdes, Contreras, Julio, Sánchez‐Pérez, Isabel, Varela‐Nieto, Isabel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021538/ https://www.ncbi.nlm.nih.gov/pubmed/33931965 http://dx.doi.org/10.1002/ctm2.363 |
Ejemplares similares
-
Transforming growth factor β1 inhibition protects from noise-induced hearing loss
por: Murillo-Cuesta, Silvia, et al.
Publicado: (2015) -
Corrigendum: Transforming growth factor β1 inhibition protects from noise-induced hearing loss
por: Murillo-Cuesta, Silvia, et al.
Publicado: (2015) -
Deficit of mitogen-activated protein kinase phosphatase 1 (DUSP1) accelerates progressive hearing loss
por: Celaya, Adelaida M, et al.
Publicado: (2019) -
Insulin-like Growth Factor 1 Signaling in Mammalian Hearing
por: García-Mato, Ángela, et al.
Publicado: (2021) -
A Comparative Study of Drug Delivery Methods Targeted to the Mouse Inner Ear: Bullostomy Versus Transtympanic Injection
por: Murillo-Cuesta, Silvia, et al.
Publicado: (2017)